Lantheus Holdings Inc (NASDAQ:LNTH) Director Derace L. Schaffer sold 10,000 shares of the stock in a transaction on Wednesday, May 10th. The shares were sold at an average price of $15.75, for a total value of $157,500.00. Following the transaction, the director now directly owns 63,730 shares of the company’s stock, valued at $1,003,747.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Lantheus Holdings Inc (NASDAQ:LNTH) traded up 4.10% during midday trading on Friday, reaching $16.50. The company had a trading volume of 886,222 shares. The firm has a 50-day moving average price of $12.53 and a 200-day moving average price of $10.48. The company has a market capitalization of $614.84 million, a price-to-earnings ratio of 27.68 and a beta of 0.29. Lantheus Holdings Inc has a 52 week low of $1.92 and a 52 week high of $16.85.

Lantheus Holdings (NASDAQ:LNTH) last issued its earnings results on Tuesday, May 2nd. The medical equipment provider reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.09. The company had revenue of $81.36 million during the quarter, compared to the consensus estimate of $77.75 million. Lantheus Holdings had a net margin of 8.64% and a negative return on equity of 12.81%. Analysts expect that Lantheus Holdings Inc will post $0.93 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This report was published by American Banking News and is owned by of American Banking News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at

A number of hedge funds and other institutional investors have recently modified their holdings of LNTH. Boothbay Fund Management LLC bought a new position in Lantheus Holdings during the fourth quarter valued at approximately $128,000. DIAM Co. Ltd. bought a new position in Lantheus Holdings during the third quarter valued at approximately $135,000. Koch Industries Inc. bought a new position in Lantheus Holdings during the first quarter valued at approximately $153,000. O Shaughnessy Asset Management LLC increased its position in Lantheus Holdings by 218.9% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 19,463 shares of the medical equipment provider’s stock valued at $167,000 after buying an additional 13,359 shares during the period. Finally, USA Financial Portformulas Corp bought a new position in Lantheus Holdings during the fourth quarter valued at approximately $225,000. 45.43% of the stock is owned by institutional investors.

Several equities analysts have weighed in on LNTH shares. Jefferies Group LLC reissued a “buy” rating and set a $15.00 price objective on shares of Lantheus Holdings in a report on Wednesday, April 26th. Zacks Investment Research raised Lantheus Holdings from a “hold” rating to a “strong-buy” rating and set a $17.00 price objective for the company in a report on Thursday, May 4th.

Lantheus Holdings Company Profile

Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.

5 Day Chart for NASDAQ:LNTH

Receive News & Ratings for Lantheus Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc and related companies with's FREE daily email newsletter.